Liu X, Shaw RH, Stuart ASV, Greenland M, et al. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet 2021 Aug 6. pii: S0140-6736(21)01694.
PMID: 34370971